The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Liquid Biopsy Diagnostic Tool Market Research Report 2025
Synopsis
Liquid Biopsy Diagnostic Tool is a medical device or technology that analyzes various biomarkers present in bodily fluids, such as blood, to detect diseases like cancer or other health conditions. It offers a less invasive alternative to traditional tissue biopsies.
The global Liquid Biopsy Diagnostic Tool market was valued at US$ 1325 million in 2023 and is anticipated to reach US$ 4462.6 million by 2030, witnessing a CAGR of 19.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy Diagnostic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy Diagnostic Tool.
Report Scope
The Liquid Biopsy Diagnostic Tool market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Biopsy Diagnostic Tool market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Biopsy Diagnostic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina
Amoy Diagnostics
Johnson & Johnson
Segment by Type
Instrument
Reagent
Others
Segment by Application
Hospital
Third-party Testing Agency
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Biopsy Diagnostic Tool companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Liquid Biopsy Diagnostic Tool is a medical device or technology that analyzes various biomarkers present in bodily fluids, such as blood, to detect diseases like cancer or other health conditions. It offers a less invasive alternative to traditional tissue biopsies.
The global Liquid Biopsy Diagnostic Tool market was valued at US$ 1325 million in 2023 and is anticipated to reach US$ 4462.6 million by 2030, witnessing a CAGR of 19.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy Diagnostic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy Diagnostic Tool.
Report Scope
The Liquid Biopsy Diagnostic Tool market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Biopsy Diagnostic Tool market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Biopsy Diagnostic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina
Amoy Diagnostics
Johnson & Johnson
Segment by Type
Instrument
Reagent
Others
Segment by Application
Hospital
Third-party Testing Agency
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Biopsy Diagnostic Tool companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instrument
1.2.3 Reagent
1.2.4 Others
1.3 Market by Application
1.3.1 Global Liquid Biopsy Diagnostic Tool Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid Biopsy Diagnostic Tool Market Perspective (2019-2030)
2.2 Liquid Biopsy Diagnostic Tool Growth Trends by Region
2.2.1 Global Liquid Biopsy Diagnostic Tool Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liquid Biopsy Diagnostic Tool Historic Market Size by Region (2019-2024)
2.2.3 Liquid Biopsy Diagnostic Tool Forecasted Market Size by Region (2025-2030)
2.3 Liquid Biopsy Diagnostic Tool Market Dynamics
2.3.1 Liquid Biopsy Diagnostic Tool Industry Trends
2.3.2 Liquid Biopsy Diagnostic Tool Market Drivers
2.3.3 Liquid Biopsy Diagnostic Tool Market Challenges
2.3.4 Liquid Biopsy Diagnostic Tool Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liquid Biopsy Diagnostic Tool Players by Revenue
3.1.1 Global Top Liquid Biopsy Diagnostic Tool Players by Revenue (2019-2024)
3.1.2 Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Players (2019-2024)
3.2 Global Liquid Biopsy Diagnostic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Biopsy Diagnostic Tool Revenue
3.4 Global Liquid Biopsy Diagnostic Tool Market Concentration Ratio
3.4.1 Global Liquid Biopsy Diagnostic Tool Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy Diagnostic Tool Revenue in 2023
3.5 Liquid Biopsy Diagnostic Tool Key Players Head office and Area Served
3.6 Key Players Liquid Biopsy Diagnostic Tool Product Solution and Service
3.7 Date of Enter into Liquid Biopsy Diagnostic Tool Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid Biopsy Diagnostic Tool Breakdown Data by Type
4.1 Global Liquid Biopsy Diagnostic Tool Historic Market Size by Type (2019-2024)
4.2 Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Type (2025-2030)
5 Liquid Biopsy Diagnostic Tool Breakdown Data by Application
5.1 Global Liquid Biopsy Diagnostic Tool Historic Market Size by Application (2019-2024)
5.2 Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liquid Biopsy Diagnostic Tool Market Size (2019-2030)
6.2 North America Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024)
6.4 North America Liquid Biopsy Diagnostic Tool Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liquid Biopsy Diagnostic Tool Market Size (2019-2030)
7.2 Europe Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024)
7.4 Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size (2019-2030)
8.2 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2019-2024)
8.4 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liquid Biopsy Diagnostic Tool Market Size (2019-2030)
9.2 Latin America Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024)
9.4 Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size (2019-2030)
10.2 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024)
10.4 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Detail
11.1.2 Biocept Business Overview
11.1.3 Biocept Liquid Biopsy Diagnostic Tool Introduction
11.1.4 Biocept Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.1.5 Biocept Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Liquid Biopsy Diagnostic Tool Introduction
11.2.4 Qiagen Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.2.5 Qiagen Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Liquid Biopsy Diagnostic Tool Introduction
11.3.4 Roche Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Introduction
11.4.4 Bio-Rad Laboratories Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Detail
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Liquid Biopsy Diagnostic Tool Introduction
11.5.4 Myriad Genetics Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.5.5 Myriad Genetics Recent Development
11.6 Menarini-Silicon Biosystems
11.6.1 Menarini-Silicon Biosystems Company Detail
11.6.2 Menarini-Silicon Biosystems Business Overview
11.6.3 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Introduction
11.6.4 Menarini-Silicon Biosystems Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.6.5 Menarini-Silicon Biosystems Recent Development
11.7 Trovagene
11.7.1 Trovagene Company Detail
11.7.2 Trovagene Business Overview
11.7.3 Trovagene Liquid Biopsy Diagnostic Tool Introduction
11.7.4 Trovagene Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.7.5 Trovagene Recent Development
11.8 Guardant Health
11.8.1 Guardant Health Company Detail
11.8.2 Guardant Health Business Overview
11.8.3 Guardant Health Liquid Biopsy Diagnostic Tool Introduction
11.8.4 Guardant Health Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.8.5 Guardant Health Recent Development
11.9 Mdxhealth
11.9.1 Mdxhealth Company Detail
11.9.2 Mdxhealth Business Overview
11.9.3 Mdxhealth Liquid Biopsy Diagnostic Tool Introduction
11.9.4 Mdxhealth Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.9.5 Mdxhealth Recent Development
11.10 Genomic Health
11.10.1 Genomic Health Company Detail
11.10.2 Genomic Health Business Overview
11.10.3 Genomic Health Liquid Biopsy Diagnostic Tool Introduction
11.10.4 Genomic Health Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.10.5 Genomic Health Recent Development
11.11 Raindance Technologies
11.11.1 Raindance Technologies Company Detail
11.11.2 Raindance Technologies Business Overview
11.11.3 Raindance Technologies Liquid Biopsy Diagnostic Tool Introduction
11.11.4 Raindance Technologies Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.11.5 Raindance Technologies Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Introduction
11.12.4 Thermo Fisher Scientific Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Illumina
11.13.1 Illumina Company Detail
11.13.2 Illumina Business Overview
11.13.3 Illumina Liquid Biopsy Diagnostic Tool Introduction
11.13.4 Illumina Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.13.5 Illumina Recent Development
11.14 Amoy Diagnostics
11.14.1 Amoy Diagnostics Company Detail
11.14.2 Amoy Diagnostics Business Overview
11.14.3 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Introduction
11.14.4 Amoy Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.14.5 Amoy Diagnostics Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Detail
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Liquid Biopsy Diagnostic Tool Introduction
11.15.4 Johnson & Johnson Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024)
11.15.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Instrument
Table 3. Key Players of Reagent
Table 4. Key Players of Others
Table 5. Global Liquid Biopsy Diagnostic Tool Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Liquid Biopsy Diagnostic Tool Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Liquid Biopsy Diagnostic Tool Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Liquid Biopsy Diagnostic Tool Market Share by Region (2019-2024)
Table 9. Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Liquid Biopsy Diagnostic Tool Market Share by Region (2025-2030)
Table 11. Liquid Biopsy Diagnostic Tool Market Trends
Table 12. Liquid Biopsy Diagnostic Tool Market Drivers
Table 13. Liquid Biopsy Diagnostic Tool Market Challenges
Table 14. Liquid Biopsy Diagnostic Tool Market Restraints
Table 15. Global Liquid Biopsy Diagnostic Tool Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Liquid Biopsy Diagnostic Tool Market Share by Players (2019-2024)
Table 17. Global Top Liquid Biopsy Diagnostic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy Diagnostic Tool as of 2023)
Table 18. Ranking of Global Top Liquid Biopsy Diagnostic Tool Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Liquid Biopsy Diagnostic Tool Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Liquid Biopsy Diagnostic Tool Product Solution and Service
Table 22. Date of Enter into Liquid Biopsy Diagnostic Tool Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Liquid Biopsy Diagnostic Tool Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Type (2019-2024)
Table 26. Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Type (2025-2030)
Table 28. Global Liquid Biopsy Diagnostic Tool Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Application (2019-2024)
Table 30. Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Application (2025-2030)
Table 32. North America Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Liquid Biopsy Diagnostic Tool Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2025-2030) & (US$ Million)
Table 47. Biocept Company Detail
Table 48. Biocept Business Overview
Table 49. Biocept Liquid Biopsy Diagnostic Tool Product
Table 50. Biocept Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 51. Biocept Recent Development
Table 52. Qiagen Company Detail
Table 53. Qiagen Business Overview
Table 54. Qiagen Liquid Biopsy Diagnostic Tool Product
Table 55. Qiagen Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 56. Qiagen Recent Development
Table 57. Roche Diagnostics Company Detail
Table 58. Roche Diagnostics Business Overview
Table 59. Roche Diagnostics Liquid Biopsy Diagnostic Tool Product
Table 60. Roche Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 61. Roche Diagnostics Recent Development
Table 62. Bio-Rad Laboratories Company Detail
Table 63. Bio-Rad Laboratories Business Overview
Table 64. Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Product
Table 65. Bio-Rad Laboratories Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 66. Bio-Rad Laboratories Recent Development
Table 67. Myriad Genetics Company Detail
Table 68. Myriad Genetics Business Overview
Table 69. Myriad Genetics Liquid Biopsy Diagnostic Tool Product
Table 70. Myriad Genetics Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 71. Myriad Genetics Recent Development
Table 72. Menarini-Silicon Biosystems Company Detail
Table 73. Menarini-Silicon Biosystems Business Overview
Table 74. Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Product
Table 75. Menarini-Silicon Biosystems Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 76. Menarini-Silicon Biosystems Recent Development
Table 77. Trovagene Company Detail
Table 78. Trovagene Business Overview
Table 79. Trovagene Liquid Biopsy Diagnostic Tool Product
Table 80. Trovagene Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 81. Trovagene Recent Development
Table 82. Guardant Health Company Detail
Table 83. Guardant Health Business Overview
Table 84. Guardant Health Liquid Biopsy Diagnostic Tool Product
Table 85. Guardant Health Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 86. Guardant Health Recent Development
Table 87. Mdxhealth Company Detail
Table 88. Mdxhealth Business Overview
Table 89. Mdxhealth Liquid Biopsy Diagnostic Tool Product
Table 90. Mdxhealth Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 91. Mdxhealth Recent Development
Table 92. Genomic Health Company Detail
Table 93. Genomic Health Business Overview
Table 94. Genomic Health Liquid Biopsy Diagnostic Tool Product
Table 95. Genomic Health Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 96. Genomic Health Recent Development
Table 97. Raindance Technologies Company Detail
Table 98. Raindance Technologies Business Overview
Table 99. Raindance Technologies Liquid Biopsy Diagnostic Tool Product
Table 100. Raindance Technologies Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 101. Raindance Technologies Recent Development
Table 102. Thermo Fisher Scientific Company Detail
Table 103. Thermo Fisher Scientific Business Overview
Table 104. Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Product
Table 105. Thermo Fisher Scientific Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 106. Thermo Fisher Scientific Recent Development
Table 107. Illumina Company Detail
Table 108. Illumina Business Overview
Table 109. Illumina Liquid Biopsy Diagnostic Tool Product
Table 110. Illumina Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 111. Illumina Recent Development
Table 112. Amoy Diagnostics Company Detail
Table 113. Amoy Diagnostics Business Overview
Table 114. Amoy Diagnostics Liquid Biopsy Diagnostic Tool Product
Table 115. Amoy Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 116. Amoy Diagnostics Recent Development
Table 117. Johnson & Johnson Company Detail
Table 118. Johnson & Johnson Business Overview
Table 119. Johnson & Johnson Liquid Biopsy Diagnostic Tool Product
Table 120. Johnson & Johnson Revenue in Liquid Biopsy Diagnostic Tool Business (2019-2024) & (US$ Million)
Table 121. Johnson & Johnson Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liquid Biopsy Diagnostic Tool Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Liquid Biopsy Diagnostic Tool Market Share by Type: 2023 VS 2030
Figure 3. Instrument Features
Figure 4. Reagent Features
Figure 5. Others Features
Figure 6. Global Liquid Biopsy Diagnostic Tool Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Liquid Biopsy Diagnostic Tool Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Third-party Testing Agency Case Studies
Figure 10. Liquid Biopsy Diagnostic Tool Report Years Considered
Figure 11. Global Liquid Biopsy Diagnostic Tool Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Liquid Biopsy Diagnostic Tool Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Liquid Biopsy Diagnostic Tool Market Share by Region: 2023 VS 2030
Figure 14. Global Liquid Biopsy Diagnostic Tool Market Share by Players in 2023
Figure 15. Global Top Liquid Biopsy Diagnostic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy Diagnostic Tool as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Liquid Biopsy Diagnostic Tool Revenue in 2023
Figure 17. North America Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Liquid Biopsy Diagnostic Tool Market Share by Country (2019-2030)
Figure 19. United States Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Liquid Biopsy Diagnostic Tool Market Share by Country (2019-2030)
Figure 23. Germany Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Share by Region (2019-2030)
Figure 31. China Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Liquid Biopsy Diagnostic Tool Market Share by Country (2019-2030)
Figure 39. Mexico Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Share by Country (2019-2030)
Figure 43. Turkey Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Biocept Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 46. Qiagen Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 47. Roche Diagnostics Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 48. Bio-Rad Laboratories Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 49. Myriad Genetics Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 50. Menarini-Silicon Biosystems Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 51. Trovagene Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 52. Guardant Health Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 53. Mdxhealth Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 54. Genomic Health Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 55. Raindance Technologies Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 57. Illumina Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 58. Amoy Diagnostics Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
